Investigational Drug Updates
Originally presented at HOPA's 14th Annual Conference, March 2018.
This presentation will discuss the pharmacology, mechanism of action, and biologic targets of a number of investigational anticancer drugs currently in clinical trials. Existing and novel drug classes and recent clinical findings will be covered. The session’s content is applicable for most attendees.
Pam Pawloski, PharmD
Patient Management & Therapeutics
The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. ACPE credit must be claimed by March 22, 2021.
This activity has been approved for .125 CEU
This course is also included as part of the Best of 2018 Annual Conference Recordings Bundle.
Release Date: September 26, 2018
Expiration Date: March 22, 2021